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Nuclear factor-B regulates genes that control im-
mune and inflammatory responses and are involved in
the pathogenesis of several diseases, including AIDS
and cancer. It has been proposed that reactive oxygen
intermediates participate in NF-B activation path-
ways, and compounds with putative antioxidant activ-
ity such as N-acetyl-L-cysteine (NAC) and pyrrolidine
dithiocarbamate (PDTC) have been used interchange-
ably to demonstrate this point. We examined their ef-
fects, separately and combined, on different stages of
the NF-B activation pathway, in primary and in trans-
formed T cells. We show that NAC, contrary to its re-
ported role as an NF-B inhibitor, can actually enhance
rather than inhibit IB degradation and, most impor-
tantly, show that in all cases NAC exerts a dominant
antagonistic effect on PDTC-mediated NF-B inhibi-
tion. This was observed at the level of IB degradation,
NF-B DNA binding, and HIV-LTR-driven reporter
gene expression. NAC also counteracted growth ar-
rest and apoptosis induced by dithiocarbamates. An-
tagonistic effects were further observed at the level
of jun-NH2-terminal kinase, p38 and ATF-2 activation.
Our findings argue against the widely accepted as-
sumption that NAC inhibits all NF-B activation path-
ways and shows that two compounds, previously
thought to function through a common inhibitory
mechanism, can also have antagonistic effects.
Key words: Antioxidant / Disulfiram / Pyrrolidine
dithiocarbamate / Reactive oxygen intermediates /
T cell transformation / Theileria.
Introduction
NF-B binds to decameric B sites which are found in the
promotors and enhancers of genes that are involved in in-
flammation, immune responses, disease, and apoptosis
(Baeuerle and Henkel, 1994; Siebenlist et al., 1994; Bald-
win, 1996). Consequently, extensive efforts are being in-
vested in identifying steps in the NF-B activation path-
way that could be blocked in a targeted manner (Poli and
Fauci, 1992; Blackwell et al., 1996; Sakurada et al., 1996).
NF-B is activated by a wide array of agents including
cytokines, oxidants such as H2O2, phorbol esters, certain
phosphatase inhibitors such as okadaic acid (OA), and UV
or ionising radiation. Different receptors, among them
members of the tumour necrosis factor receptor family
that participate in apoptosis (Nagata, 1997), also activate
NF-B. In addition, NF-B may participate in the patho-
genesis of diseases caused by viruses and bacteria (re-
viewed in Baeuerle and Henkel, 1994; Baldwin, 1996).
More recently, the list of NF-B inducers has been extend-
ed to parasites such as Toxoplasma (Gazzinelli et al.,
1996), Plasmodium (Schofield et al., 1996) and Theileria
(Ivanov et al., 1989; Palmer et al., 1997) which interfere
with host cell signalling pathways.
The NF-B/Rel family of proteins consists of p50
(NFB1), p52 (NFB2), p65 (RelA), c-Rel and RelB (re-
viewed in Verma et al., 1995; Baeuerle and Baltimore,
1996; Baldwin, 1996). These proteins share a conserved
‘Rel homology domain’ through which they can form ho-
modimers or heterodimers which bind DNA. In most cell
types, NF-B is sequestered in the cytoplasm in a latent
form in association with inhibitory IB proteins, of which
IB and IB are the best characterised. Activation of
NF-B has been shown to involve signal-induced IB
phosphorylation by IB kinases (reviewed in Stancovski
and Baltimore, 1997). IB phosphorylation and subse-
quent ubiquitination targets the protein for proteosomal
degradation (Palombella et al., 1994; Traenckner et al.,
1994; DiDonato et al., 1996). Ubiquitination-independent
IB degradation (Lee et al., 1997a) also occurs, however,
and may be involved in regulating basal IB turnover
(Krappmann et al., 1996). 
Numerous studies suggest that reactive oxygen
species (ROS) serve as common intracellular mediators
of IB degradation and subsequent NF-B activation
(Schulze Osthoff et al., 1993; Baeuerle and Henkel, 1994;
Baeuerle et al., 1996; Sen and Packer, 1996; Flohé et al.,
1997). Consistent with this hypothesis, it has been shown
that a variety of structurally diverse antioxidants are capa-
ble of inhibiting NF-B activation. A number of studies,
however, also suggest that not all NF-B activation path-
ways involve ROS, as judged by their resistance to anti-
oxidants (Suzuki et al., 1994; Brennan and O’Neill, 1995;
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Flohé et al., 1997). N-acetyl-L-cysteine (NAC) and pyrroli-
dine dithiocarbamate (PDTC) are two compounds that
have been used extensively as NF-B inhibitors (Schreck
et al., 1992; Meyer et al., 1994). NAC, a glutathione (GSH)
precursor and ROS scavenger, inhibits NF-B activation
induced by a range of stimuli in several, but not all, cell
types (Schreck et al., 1991; Meyer et al., 1993). PDTC, a
dithiol compound often used because of its reported an-
tioxidant activity, is a more consistent inhibitor of NF-B
which appears to act more independently of the activating
agent and cell line used (Schreck et al., 1991; Galter et al.,
1994; Mihm et al., 1995). PDTC has recently also been
shown to induce G1 cell-cycle arrest and apoptosis in ma-
lignant cell lines and to enhance the anti-tumour efficacy
of chemotherapeutic agents, prompting the proposal that
PDTC may find application in combination therapy (Chin-
ery et al., 1997).
The fact that NAC and PDTC can independently inhibit
NF-B activation has been used in support of a general
model in which NF-B activation is governed by oxidative
stress (Schreck et al., 1991). Evidence is emerging, how-
ever, that the major mode of inhibitory action of PDTC may
not be restricted to its antioxidant activity, but could also
include metal ion chelating (Bessho et al., 1994; Brennan
and O’Neill, 1995) and even pro-oxidant properties (Nobel
et al., 1995; Brennan and O’Neill, 1996b; Pinkus et al.,
1996). In this context, PDTC-dependent activation of the
transcription factor AP-1 was shown to depend on its
pro-oxidant activity and could be blocked by anti-oxi-
dants, including GSH and NAC, its synthetic precursor
(Pinkus et al., 1996). In the present study, we investigated
whether such antagonistic effects also existed at the level
of the NF-B activation in primary lymph node (LN) T cells
and on induced and constitutive NF-B activation in trans-
formed T cells. We report that the GSH precursor, NAC,
which is generally accepted as an antioxidant inhibitor of
NF-B, can actually enhance NF-B activation rather than
inhibit it, and, more importantly, we demonstrate that the
inhibitory effects of dithiol compounds such as PDTC and
disulfiram on NF-B activation are neutralised completely
by NAC. This effect can be observed at the level of IB
and IB degradation, NF-B DNA binding activity, NF-B
transcriptional activity and dithiocarbamate-induced
growth arrest and apoptosis. Our findings demonstrate
that these classical NF-B inhibitors, previously thought
to function through a common antioxidant mechanism,
can have completely diverging and antagonistic effects on
NF-B activation pathways. 
Results
NAC Enhances Basal IB Degradation
IBa, in particular the uncomplexed form, is inherently un-
stable and undergoes a continuous turnover in the ab-
sence of NF-B-inducing signals (Miyamoto et al., 1994;
Krappmann et al., 1996). This is most apparent when de
novo synthesis is blocked by the protein synthesis in-
hibitor cycloheximide (CHX). When resting LN Tcells were
cultured in the presence of CHX (Figure 1A), basal levels
of IB turnover could be demonstrated by a modest
reduction in the amounts of IB protein detected by
Western blot analysis. Whereas PDTC treatment showed
no effect, NAC actually enhanced IB turnover, indicat-
ing that the two compounds affect basal IB turnover
differently. This finding was surprising, since NAC, as an
antioxidant and ROS scavenger, was expected to inhibit
rather than enhance IB degradation.
NAC Blocks PDTC-Mediated Inhibition of
IB Degradation
In order to investigate whether this observation could be
confirmed in cells in which the NF-B activation pathway
is constitutively activated, we next tested the effect of
NAC and PDTC on IB degradation in transformed Tcells.
As a source of transformed Tcells, we used Theileria
parva-infected Tcells (Tpi Tcells) which proliferate conti-
nuously and behave as persistently activated Tcells (Dob-
belaere et al., 1988; Eichhorn et al., 1993; Galley et al.,
1997). In Tpi Tcells, NF-B is constitutively activated, in-
volving the continuous degradation of both IB and IB
and nuclear translocation of several members of the
NF-B/Rel family. Steady-state levels of IB were not sig-
Fig.1 Effect of NAC and PDTC on IB Degradation in Resting
LN T Cells and Transformed Tpi T Cells.
(A) Basal IB turnover in LN Tcells is enhanced by NAC. LN T
cells were cultured in the presence or absence of CHX to inhibit de
novo IB synthesis and treated with NAC or PDTC, as indicated.
Whole cell extracts (15g/lane) were examined by immunoblot
analysis using anti-IB Ab. The position of IB is indicated by
an open triangle. 
(B) Effect of NAC and PDTC on constitutive IB degradation in Tpi
Tcells. Tpi Tcells were cultured in the presence of CHX, NAC or
PDTC as indicated and whole cell extracts (20 g/lane) examined
by immunoblot analysis using anti-IB and anti-IB Ab togeth-
er. The positions of IB and IB are indicated by open triangle
and closed triangles, respectively. The upper open triangle marks
phosphorylated IB.
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nificantly affected by NAC or PDTC treatment except for a
slight reduction in the amount of phosphorylated IB in
PDTC-treated cells (data not shown). Blocking de novo
protein synthesis in Tpi Tcells by treatment with CHX for
4 h resulted in decreased levels of both IB and IB
compared to untreated cells (Figure 1B), reflecting the
constitutive degradation of IB (Palmer et al., 1997). As
was observed for basal degradation in primary LN Tcells,
NAC enhanced constitutive IB degradation. Treatment
with PDTC clearly prevented IB degradation. Further-
more, in the presence of NAC, the inhibition of IB degra-
dation by PDTC was totally abrogated, demonstrating that
the antioxidant NAC can block the effect of PDTC at the
level of IB degradation. OA is a strong activator of NF-B
and induces the rapid phosphorylation and degradation of
IB (Rieckmann et al., 1992; Menon et al., 1995), most like-
ly by blocking protein phosphatase 2A which inactivates
IB kinase (DiDonato et al., 1997). In earlier work, it has
been proposed that OA induces IB degradation down-
stream of the anti-oxidant-sensitive step in the NF-B
activation cascade (Suzuki et al., 1994; Sen and Packer,
1996). When resting LN Tcells were stimulated with OA,
IB was phosphorylated and rapidly degraded (Figure
2A) and in agreement with earlier reports (Suzuki et al.,
1994; Sen and Packer, 1996), IB degradation was not
inhibited by NAC, PDTC or a combination of both. OA-in-
duced IB degradation was also restricted to IB and no
IB degradation could be detected. In the transformed
Tpi Tcells, OA also induced the complete degradation of
IB (Figure 2B). In contrast to resting LN Tcells in which
IB levels were not affected by OA, significant IB
degradation could be detected in transformed Tpi Tcells.
Only a faint IB band (small closed triangle) could be de-
tected upon OA treatment, and degradation was again en-
hanced by NAC. PDTC largely prevented the OA-induced
degradation of IB, but not that of IB. The stabilisation
of IB conferred by PDTC was completely prevented by
NAC, demonstrating that the antagonistic effect of NAC
on PDTC can occur both at the level of constitutive IB
turnover and OA-induced IB degradation. Triggering of T
cell surface receptors for TNF, IFN, IL1 or stimulation of
CD95/Fas or CD28 generates ceramide via hydrolysis of
sphingomyelin by sphingomyelinases (reviewed in Ballou
et al., 1996). Ceramide is an important signal transducer
of NF-B activation. N-acetylsphingosine, a membrane-
permeable synthetic form of ceramide, was used to test
the effect of PDTC and NAC on ceramide-induced IB
degradation in Tpi Tcells. Within 1 h of ceramide treat-
ment, IB was strongly reduced and IB had all but dis-
appeared. PDTC inhibited the ceramide-induced degra-
dation of both IB and IB. NAC further enhanced IB
degradation and the PDTC-mediated inhibition of IB
degradation was again prevented by NAC (not shown).
The Antagonistic Effect of NAC on PDTC
Is Also Evident at the Level of NF-B DNA Binding
and Transcriptional Activity
In previous work we have shown by electrophoretic mobil-
ity shift assay (EMSA) that T. parva induces NF-B activa-
tion resulting in the appearance of different B binding
complexes in the nucleus (Ivanov et al., 1989). NF-B tran-
scriptional activity in Tpi Tcells was also shown to be re-
sistant to NAC and only partly reduced by treatment with
PDTC (Palmer et al., 1997). Consistent with these obser-
vations, NAC had no inhibitory effect on NF-B DNA bind-
ing activity (Figure 3); on the contrary, in agreement with
the enhanced IB degradation induced by NAC, DNA
binding was often moderately increased in the presence of
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Fig.2 Effect of NAC and PDTC on OA-Induced IB Degradation
in Resting LN TCells and Transformed Tpi TCells. 
(A) NAC and PDTC have no effect on OA-induced IB degrada-
tion in resting LN T cells. LN Tcells were stimulated with OA in the
presence or absence NAC or PDTC as indicated. The position of
IB (lower open triangle) and its phosphorylated form (upper
open triangle) and the position of IB (closed triangle) are indi-
cated.
(B) Tpi Tcells were stimulated with OA in the presence or absence
of NAC and PDTC and protein extracts were analysed for IB
levels as above.
Fig.3 Influence of NAC and PDTC on NF-B DNA Binding
Activity.
NF-B translocation and DNA binding in Tpi Tcells is partially in-
hibited by PDTC, but not by NAC, and NAC counteracts PDTC-
mediated inhibition. Tpi Tcells were left untreated or treated for
5 h with PDTC and NAC as indicated. Nuclear lysates were
prepared from 107 cells and NF-B binding to [32P]-labelled oligo-
nucleotides representing consensus B recognition sites deter-
mined by EMSA. The arrowhead indicates the NF-B complex
which is most affected by PDTC. The lane labelled ‘comp’, shows
an assay in which an excess of unlabelled oligonucleotide includ-
ed in the EMSA as a control for binding specificity.
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NAC. PDTC treatment resulted in a partial inhibition of
DNA binding, affecting predominantly the faster migrating
NF-B complex (marked by an arrowhead). NAC com-
pletely restored NF-B DNA binding in PDTC-treated cells
as shown by the reappearance of the lower complex.
Treatment of Tpi cells with OA resulted in increased NF-B
binding activity (not shown) and consistent with the obser-
vations made for IB, NAC did not inhibit either quantita-
tive or qualitative changes. Treatment with PDTC, on the
other hand, resulted in reduced NF-B DNA binding activ-
ity, but this effect was at least partly blocked when cells
were simultaneously treated with NAC (data not shown).
To test whether the antagonistic effects of NAC on the
activity of PDTC could also be demonstrated at the level of
NF-B transcriptional activity, transient transfection ex-
periments were performed using the reporter plasmid HIV-
CAT. In this plasmid, expression of the chloramphenicol
acetyl transferase (CAT) gene is placed under the control
of the two B binding sites within the HIV-LTR. As shown
before for Tpi Tcells (Palmer et al., 1997), the constitutive
NF-B transcriptional activity, monitored by CAT activ-
ity, was not inhibited by NAC (Figure 4A), but was
reduced by 62% when cells were treated with PDTC. No
reduction in CAT activity could be observed, however,
when cells were treated simultaneously with both com-
pounds. The effects of both compounds on basal NF-B
transcriptional activity in Jurkat Tcells was identical to
that observed in Tpi Tcells, with CAT activity reduced by
57% in the presence of PDTC (data not shown). In Tpi T
cells, NF-B is maximally induced and can not be activat-
ed further. Stimulation of Jurkat Tcells with TPA and iono-
mycin, however, resulted in a 4.8-fold induction above
basal activity (Figure 4B), which was completely inhibited
by PDTC. NAC did not interfere with the induction of
Fig.4 PDTC-Mediated Inhibition of NF-B Dependent Reporter Gene Expression Is Abolished by NAC.
(A) Tpi Tcells, in which NF-B is constitutively activated, were transfected with the plasmid HIV-CAT, in which CAT expression is stimulat-
ed through two B binding sites. Transfected cells were either untreated or incubated with PDTC and/or NAC for 24 h prior to determina-
tion of CAT activity. Results represent one of at least three separate experiments and are expressed as % of CAT activity in untreated HIV-
CAT-transfected cells. Bars represent the mean value (± S.D., n =3).
(B) Effect of NAC and PDTC on NF-B-dependent reporter gene expression in HIV-CAT-transfected Jurkat Tcells, induced by treatment
with TPA and ionophore. Results from one of at least three experiments are presented as fold induction compared to unstimulated Jurkat
Tcells. Bars represent the mean value (± S.D., n = 3).
Fig.5 NAC Prevents PDTC-Induced Growth Arrest and Apoptosis.
(A) Jurkat Tcells were cultured overnight in the presence or absence of PDTC and NAC at the indicated doses. Cells were labelled with
[methyl-3H]thymidine ([3H]TdR) the last 5 h of culture and [3H]TdR incorporation measured. Data are presented as cpm  10–3 per 4  104
cells seeded. Error bars represent 1 SD of the mean of values from triplicate cultures. (B) Jurkat Tcells were cultured for 16 h in the pres-
ence of PDTC (10 g/ml) alone (solid line) or PDTC and NAC (30mM) together (dotted line), and analysed by flow cytometry for the binding
of fluoresceine-labelled annexin-V. The grey profile shows annexin-V binding to control cells treated with NAC alone. Propidium iodide
DNA staining was used to exclude necrotic cells from the analysis.
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NF-B and again prevented PDTC-mediated inhibition of
NF-B activation. These data confirm that the antagonis-
tic effect of NAC on PDTC-mediated inhibition of NF-B
activation can be observed at several levels of the activa-
tion cascade.
NAC Counters PDTC-Induced Growth Arrest
and Apoptosis in Transformed T Cells
There are conflicting reports on the effect of PDTC on pro-
liferation and apoptosis. PDTC has been reported to in-
duce apoptosis in thymocytes (Nobel et al., 1995) and tu-
mour cells (Chinery et al., 1997; Giri and Aggarwal, 1998).
On the other hand, PDTC has also been shown to protect
cells from apoptosis (Albrecht et al., 1994; Bessho et al.,
1994; Mihm et al., 1995). The proliferation of both Tpi and
Jurkat Tcells was monitored by [methyl-3H]thymidine in-
corporation and found to be potently inhibited by micro-
molar amounts of PDTC. In both cases, however, the
PDTC-induced proliferation arrest was reversed by co-
treatment with NAC (Figure 5A). In order to determine
whether growth arrest was followed by apoptosis, the ex-
pression of phosphatidylserine was also monitored. Du-
ring the induction of apoptosis, changes occur at the cell
surface, including the translocation of phosphatidylserine
(PS) from the inner part of the plasma membrane to the
outer layer. Annexin-V is a PS-binding protein which binds
with high affinity to PS and can be detected by flow cy-
tometry (Verhoven et al., 1995). When Jurkat Tcells were
treated for 16 h with PDTC, the majority of cells exposed
PS on their surface (Figure 5B). A clear reduction in annex-
in-V binding could be observed, however, when cells were
cultured in the presence of both PDTC and NAC, demon-
strating that NAC is capable of preventing PDTC-induced
apoptosis in Jurkat Tcells. Identical results were obtained
for Tpi Tcells (not shown).
Effects of NAC and PDTC on jun-NH2-Terminal
Kinase (JNK), p38 and ATF-2
Many stimuli that induce NF-B also activate the MAP ki-
nase family members JNK and p38. Previous work has
shown that NAC and PDTC can both induce JNK in Jurkat
Tcells (Gomez del Arco et al., 1996). We tested whether
this also applied to resting LN Tcells and whether NAC
could block PDTC-induced effects. Basal JNK and p38
activity and their induction by osmotic shock were exam-
ined. Nuclear extracts from LN Tcells were subjected to
Western blot analysis, using antibodies (Ab) directed
against phosphorylated forms of c-Jun and p38. Phos-
phorylation of c-Jun, detectable by anti-phospho-c-Jun
Ab, reflects JNK activity; likewise, p38 activation is ac-
companied by specific p38 autophosphorylation. PDTC
treatment resulted in increased c-Jun phosphorylation in
resting LN Tcells and also in cells that were subjected to
mild osmotic shock (Figure 6A, lanes 3 and 7). NAC weak-
ly super-induced JNK activation only in NaCl-treated cells.
PDTC-mediated JNK activation, however, was potently
inhibited when NAC was present (compare lanes 3 and 4,
lanes 7 and 8). In Tpi Tcells, in which JNK is constitutively
activated (Galley et al., 1997), superinduction of JNK by
PDTC was also blocked by NAC (data not shown). A basal
level of p38 activity could be detected in resting LN Tcells
which was not observed in the presence of NAC. PDTC
treatment did not result in additional p38 activity. In LN T
cells subjected to osmotic shock, p38 was clearly upregu-
lated and this was enhanced by NAC or PDTC treatment.
In the presence of both compounds, however, the levels of
phospho-p38 were markedly reduced.
The JNK and p38 pathways have been reported to reg-
ulate the phosphorylation and activation of transcription
factors such as AP-1 and ATF-2 (Gupta et al., 1995) (re-
viewed in Whitmarsh and Davis, 1996). It has previously
been described that PDTC-induced AP-1 activation can
be inhibited by glutathione and NAC (Pinkus et al., 1996).
We investigated whether this also applied to ATF-2. Acti-
vation of ATF-2 is accompanied by changes in its phos-
phorylation pattern, resulting in the appearance of addi-
tional bands with reduced electrophoretic mobility. Total
cellular extracts from Tpi and resting LN Tcells were
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Fig.6 Effects of NAC and PDTC on JNK, p38 and ATF-2 Activa-
tion. 
(A) Effect in resting LN Tcells and LN Tcells subjected to osmotic
shock. Resting LN Tcells (lanes 1–4) or LN Tcells subjected to
osmotic shock (0.2 M NaCl for 20 min; lanes 5–8) were cultured in
the presence or absence of PDTC and NAC. Nuclear extracts
were analysed by immunoblotting, using Ab specific for phos-
pho-c-Jun (top panel) or phospho-p38 (lower panel). Closed ar-
rows point at the specific phospho-c-Jun and phospho-p38
bands. In the lower panel, the position of a non-specific band (ns)
is indicated by an open arrow. 
(B) Effect of NAC and PDTC on ATF-2 activation in Tpi Tcells sub-
jected to osmotic shock. Immunoblot analysis of extracts pre-
pared from Tpi Tcells that were either untreated or submitted to
osmotic shock (even numbers) in the presence or absence of
NAC and PDTC. The filter was probed with an anti-ATF-2 Ab; un-
phosphorylated and phosphorylated ATF-2 are indicated by open
and closed arrowheads, respectively.
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subjected to immunoblot analysis, using Ab specific for
ATF-2. Marked changes in ATF-2 phosphorylation pat-
terns could be observed in Tpi or LN Tcells that were sub-
jected to osmotic shock (shown for Tpi Tcells in Fig-
ure 6B, even numbers). NAC treatment did not induce any
changes, but ATF-2 phosphorylation was more pro-
nounced in the presence of PDTC (Figure 6B, compare
lanes 2 and 4) and the pattern of intensity of the different
bands was also altered. In the presence of both NAC and
PDTC, however, ATF-2 phosphorylation induced by os-
motic shock was significantly reduced (Figure 6B, com-
pare lanes 4 and 8). Thus, PDTC can enhance both AP-1
(Pinkus et al., 1996) and ATF-2 activation and, in both cas-
es, these effects are reversed by NAC.
NAC Also Counteracts the Inhibitory Effects
Induced by Another Thiol, Disulfiram
Finally, we determined whether NAC could counteract the
action of dithiol compounds other than PDTC. Disulfiram,
a drug used for alcohol aversion therapy, is also a potent
inhibitor of NF-B (Schreck et al., 1992). Disulfiram treat-
ment of Tpi Tcells resulted in a strong inhibition of NF-B
DNA binding (Figure 7A). Although the pattern of inhibition
was different from that caused by PDTC, disulfiram-medi-
ated NF-B inhibition was completely prevented by NAC.
Inhibition of NF-B activation by non-thiol compounds
such as o-phenanthroline and desferrioxamine, on the
other hand, was not blocked by NAC (data not shown).
Transfection studies with HIV-CAT plasmid showed that
disulfiram treatment resulted in a significant reduction in
CAT activity (Figure 7B) which was reversed by NAC. As
was the case for PDTC, disulfiram caused rapid growth
arrest and apoptosis of Jurkat and Tpi Tcells, which was
counteracted when NAC was added to the culture medi-
um. Figure 7C shows a typical experiment using Tpi Tcells
in which proliferation was monitored by measuring
[methyl-3H]thymidine incorporation. Disulfiram potently
blocked proliferation, but this did not occur in the pres-
ence of NAC. An identical pattern was again observed for
Jurkat Tcells (not shown).
Discussion
Lack of Susceptibility to Inhibition by NAC
Many inducers of NF-B activation are known to result in
the generation of intracellular ROS (Schreck et al., 1992;
Meyer et al., 1994) (reviewed in Schreck and Baeuerle,
Fig.7 NAC Blocks Disulfiram-Mediated Inhibition of NF-B and Disulfiram-Induced Growth Arrest.
(A) NAC prevents disulfiram-mediated inhibition of NF-B activation. Tpi Tcells were left untreated or treated with disulfiram (1M) and/or
NAC (30 mM) for five hours. Nuclear extracts were examined by EMSA as described for Figure 3.
(B) The inhibition of NF-B transcriptional activity by disulfiram is prevented by NAC. Tpi Tcells were transfected with the plasmid HIV-
CAT. Constitutive NF-B transcriptional activity was monitored in transfected cells that were either left untreated or incubated with disul-
firam (1M) and/or NAC (30 mM) for 24 hours prior to determining of CAT activity. One of two separate experiments is shown and results
are expressed as % of CAT activity in untreated control cells. Bars represent the mean value (± S.D., n = 3).
(C) Disulfiram-induced arrest of proliferation is prevented by NAC. Tpi Tcells were cultured for 24 h in the presence or absence of disulfi-
ram and NAC at the indicated doses. Cells were labelled with [methyl-3H]thymidine ([3H]TdR) for the last 5 h of culture and incorporation
measured by liquid scintillation counting. Data are presented as cpm  10–3 per 4  104 cells seeded. Error bars represent 1 SD of the mean
of values from triplicate cultures.
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1994). This, together with the fact that NF-B activation
can be inhibited by antioxidants, has lead to the proposal
that ROS serve as second messengers in most, if not all,
NF-B activation pathways (Schreck et al., 1991; Schreck
and Baeuerle, 1994). In these studies, NAC and dithiols
have been used interchangeably to underpin this theory.
Thus, both PDTC and NAC have been shown to inhibit the
synthesis of IL-6, IL-8, and GM-CSF induced by TNF or
bacterial lipopolysaccharides (LPS) in human umbilical
vein endothelial cells (Munoz et al., 1996) and similar ob-
servations were made in other systems (Lee et al., 1997b;
Kikumori et al., 1998). Contrary to our findings, NAC has
also been shown to inhibit NF-B activation in a number of
Tcell lines (Dröge et al., 1991; Mihm et al., 1995). The con-
cept that NF-B is a sensor for oxidative stress has re-
cently been challenged more directly (Li and Karin, 1999)
and arguments against a general involvement of ROS in
NF-B activation are accumulating (Suzuki et al., 1994,
1995) (reviewed in Flohé et al., 1997; Li and Karin, 1999).
NAC failed to inhibit the activation of NF-B by classical
NF-B-inducing agents such as IL-1, TNF and TPA in
some cell lines, but not in others (Brennan and O’Neill,
1995; Bowie et al., 1996). Likewise, in the T lymphocytic
cell line, CEM, NF-B activation by PMA was resistant to
NAC (Legrand Poels et al., 1997). These findings indicate
that the ROS model of NF-B activation and sensitivity to
NAC is restricted to certain cell types. Furthermore, H2O2
does not invariably activate NF-B (Israel et al., 1992;
Anderson et al., 1994; Brennan and O’Neill, 1995) and
studies involving the transient overexpression of catalase
suggest that H2O2 may not always serve as a second mes-
senger in NF-B activation (Suzuki et al., 1995). Defining
the exact role of H2O2 (or other ROS) as an integratory sec-
ondary messenger for different Tcell signals has indeed
been complicated by the fact that various Tcell lines and
peripheral blood Tcells can differ markedly – also within
one cell line – in the levels of NF-B activation induced by
oxidant stress (Ginn Pease and Whisler, 1998). Various
factors appear to regulate the responsiveness, since it has
been shown that optimal NF B-mediated transcriptional
responses in Jurkat Tcells exposed to oxidative stress are
dependent on intracellular glutathione and costimulatory
signals (Ginn Pease and Whisler, 1996). The nature of the
stimulus may also play a role. For instance, it has been
shown that NAC and PDTC were also not able to block
daunomycin-induced NF-B activation or p53 induction,
indicating that ROI are not involved in the cellular response
to daunomycin stimulation (Hellin et al., 1998).
A consistent observation in our work was the general
lack of inhibitory activity observed for NAC in the systems
that were tested. Assuming that NAC is an antioxidant
which indeed blocks the effects of ROS, our observations
strengthen the concept that the ROS-dependence of NF-
B activation may not be as strict or widespread as previ-
ously proposed (Schulze Osthoff et al., 1997) and also ar-
gue in favour of cell-type restriction. Moreover, and con-
trary to expectations, NAC enhanced rather than inhibited
IB degradation. Indeed, we found the basal IB turn-
over in resting LN Tcells, the constitutive degradation in
transformed Tpi Tcells, and OA- or ceramide-induced IB
degradation to be enhanced in the presence of NAC.
While this observation may be unexpected, NAC-mediat-
ed NF-B activation is not without precedent. It has re-
cently been reported that treatment of macrophages with
NAC resulted in increased NF-B activity which correlated
with an up-regulation of HIV production (Nottet et al.,
1997).
NAC Blocks PDTC-Mediated Inhibition of NF-B
One of the salient observations of our work was that NAC
consistently blocked the PDTC-mediated inhibition of the
NF-B activation pathway, irrespective of the way in which
NF-B activation was induced. This could be observed at
the level of IB degradation, NF-B DNA binding and tran-
scriptional activity. These findings are not compatible with
the proposed common mode of action for PDTC and NAC,
in which both compounds are thought to inhibit NF-B ac-
tivation through their antioxidant activity (Meyer et al.,
1993, 1994). Does PDTC really function as an antioxidant?
Dithiocarbamates can induce a variety of other biological
effects in mammalian cells (Sen and Packer, 1996; Flohé
et al., 1997). A number of studies suggest that the inhibi-
tion of NF-B by PDTC and other dithiocarbamates oc-
curs through their metal ion chelating properties (Bessho
et al., 1994; Brennan and O’Neill, 1995; Nobel et al., 1995)
and several other, non-thiol metal chelators such as
o-phenanthroline and desferrioxamine also inhibit NF-B
(Schreck et al., 1992). Nevertheless, we found that the in-
hibitory effect of the latter two compounds was not
blocked by NAC, suggesting that NAC probably does not
act by blocking the potential metal chelating properties of
PDTC. In addition, it has been proposed that PDTC may
cause GSH oxidation, resulting in GSSG accumulation, by
a non-radical mechanism (Ziegler, 1991). Brennan and
O’Neill (1996a) also reported PDTC pro-oxidant activity,
resulting in increased levels of GSSG which can affect the
binding of NF-B to DNA. In addition, PDTC pro-oxidant,
rather than antioxidant, activity has been shown to be
responsible for inducing AP-1 activation (Pinkus et al.,
1996). NF-B activation apparently requires optimal levels
of GSSG (Dröge et al., 1994) which is regulated in a com-
plex manner. At low GSSG levels, Tcells cannot optimally
activate NF-B, whereas high GSSG levels inhibit the DNA
binding activity of NF-B. The effects of GSSG, in turn, are
antagonized by reduced thioredoxin (Dröge et al., 1994)
which has distinct roles in the cytoplasm and in the nucle-
us (Flohé et al., 1997). Considered together, it is conceiv-
able that NAC, as a precursor of GSH, counteracts the
effects of increased GSSG levels induced by PDTC pro-
oxidant activity, by restoring the intracellular redox equi-
librium. Recent work, however, has shown that the effects
of NAC on Tcell apoptosis are not mediated by increased
cellular glutathione (Jones et al., 1995). NAC, in its capac-
ity of a thiol, may also counter the pro-oxidant activity of
PDTC more directly. That this may indeed be the case is
strongly supported by recent observations made in our
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laboratory showing that both L-cysteine and D-cysteine
(which can not be incorporated into GSH) on their own are
capable of blocking growth inhibition and apoptosis in-
duced by PDTC in Tpi and Jurkat Tcells (VH unpublished
observation). Our observations also point towards a num-
ber of differences in the regulation of the IB and IB
degradation pathways. As has also previously been ob-
served for Jurkat Tcells and U937 monocytic cells (Suzu-
ki et al., 1994; Sen and Packer, 1996), OA-induced degra-
dation of IB could not be inhibited by PDTC in Tpi T
cells. OA-induced degradation of IB, on the other hand,
was blocked (Figure 2B), demonstrating a differential sen-
sitivity of the IB and IB degradation pathways to
PDTC-mediated inhibition. We also observed that OA was
capable of inducing IB degradation in the transformed
Tpi Tcells, but not in resting LN Tcells. This is reminiscent
of the observations by Menon et al. (1993), who showed
that OA treatment failed to induce nuclear translocation of
NF-B in several primary cell lines, whereas rapid induc-
tion by OA could readily be detected in their SV40-trans-
formed counterparts. Both sets of observations support
the concept that the regulation of IB degradation path-
ways can differ depending on the state of activation of the
cell.
NAC Blocks Apoptosis Induced by PDTC
Tpi and Jurkat Tcells proved highly sensitive to PDTC and
disulfiram, undergoing rapid cell cycle arrest and apopto-
sis. The fact that these processs are averted by NAC
points towards different modes of action. 
In other systems, PDTC and NAC either induce or inhib-
it apoptosis, depending on the cell line and the stimulus
(Bessho et al., 1994; Talley et al., 1995; Kaneto et al., 1996;
Ivanov et al.,1997). In cancer cells, PDTC can induce apop-
tosis and it also potentiates the activity of chemothera-
peutic agents at doses that are not toxic to a range of un-
transformed epithelial cells (Chinery et al., 1997). For this
reason, clinical trials for the treatment of colorectal cancer
and other solid tumours have been proposed, in which
PDTC could be used in combination with chemotherapeu-
tic agents (Chinery et al., 1997). Our observations suggest
that the potentiating, beneficial effects of PDTC during
such treatment may not be possible in the presence of a
drug such as NAC. 
Interestingly, the anti-apoptotic effect of NAC is not
specific for apoptosis induced by PDTC. In recent work,
we demonstrated that NAC also blocs apoptosis in-
duced by the alkylating agent N--tosyl-L-phenylalanine
chloromethyl ketone (Heussler et al., 1999a), which in-
hibits the NF-B activation pathway in Tpi Tcells by block-
ing IB phosphorylation (Heussler et al., 1999b).
Effects of NAC and PDTC on Other
Signalling Pathways
AP-1, another key transcription factor, is also subject to
redox regulation and its activation is also affected by
PDTC and NAC (Meyer et al., 1993; Munoz et al., 1996;
Pinkus et al., 1996; Yokoo and Kitamura, 1996). AP-1
transactivation is influenced by the intracellular thioredox-
in and GSH status. PDTC, rather than inhibiting, induces
AP-1-regulated gene expression. Such opposite effects
on NF-B and AP-1 activation have also been document-
ed for H2O2, thioredoxin and a number of other com-
pounds (Meyer et al., 1993; Galter et al., 1994; Schenk et
al., 1994). Interestingly, Pinkus et al. (1996) demonstrated
that PDTC-induced AP-1 activation is inhibited by pre-ex-
posure of cells to GSH or antioxidants, including NAC.
This is in line with our observations for the MAP kinase
family members JNK and p38, and for the transcription
factor ATF-2 which can be regulated by JNK and p38
(Gupta et al., 1995; Raingeaud et al., 1995; van Dam et al.,
1995; Wilhelm et al., 1995). Treatment with PDTC en-
hanced JNK activation and this was blocked by NAC. In
cells subjected to osmotic shock, JNK and p38 activity
were enhanced by both NAC and PDTC, but strongly re-
duced in the presence of both components. NAC and
PDTC, applied separately, did not interfere with ATF-2 ac-
tivation induced by osmotic shock. On the contrary, PDTC
tended to enhance ATF-2 phosphorylation. When osmot-
ic shock was applied in the presence of both compounds,
however, a clear reduction in the levels of phosphorylated
ATF-2 could be observed. Our findings thus show that
NAC blocks the effects exerted by PDTC on different sig-
nalling pathways, be they inhibitory, as is the case for NF-
B, or stimulatory, as was found for AP-1 and ATF-2. It has
been reported that NF-B activation can be regulated by
MEKK-1 (Hirano et al., 1996; Meyer et al., 1996; Lee et al.,
1997a), a kinase which also controls the activation of JNK
and p38. The physiological significance of MEKK1 vs. NIK
or other kinases activators of IKK, however, has not yet
been fully elucidated (Karin and Delhase, 1998).
Nevertheless, despite the fact that the NF-B and
JNK/p38 pathways may at one stage be regulated by a
common upstream element, pathways further down-
stream clearly appear to differ in their sensitivity to NAC
and PDTC (Pinkus et al., 1996).
NF-B represents a prime target for therapeutic inter-
vention since blocking NF-B activation inhibits both the
production of inflammatory cytokines (such as TNF-,
IL1- and IL6) by immune and endothelial cells (Munoz et
al., 1996) and the deleterious cellular changes induced by
cytokines (Barnes and Adcock, 1997). NF-B and AP-1
binding sites are also present in the promoter region of a
number of genes that are directly involved in the patho-
genesis of AIDS and cancer. The LTR of HIV-1 contains B
binding sites which may play a crucial role in regulating the
latency of AIDS (Griffin et al., 1989) and one of the major
consequences of NF-B activation is HIV gene transcrip-
tion. Antioxidants such as NAC, dithiocarbamates and a
wide variety of chemically unrelated inhibitors have been
shown to block NF-B activation or transcription directed
by the HIV-LTR (Roederer et al., 1990; Staal et al., 1993)
suggesting a possible therapeutic value in the clinical
treatment of HIV-infected patients (Lemarie et al., 1986;
Reisinger et al., 1990; Sunderman, 1991; Dröge et al.,
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1992; Roederer et al., 1992). As mentioned before, howev-
er, NAC can also enhance acute HIV-1 replication in mono-
cyte-derived macrophages (Nottet et al., 1997) and we
now show that NAC can also counteract the inhibitory ef-
fects of dithiol compounds on HIV-LTR-driven reporter
gene expression in Tcells. In conclusion, it is becoming
more and more obvious that NF-B responses, and the
extent to which they can be inhibited, differ significantly
according to cell type, stimulus or state of activation of the
cell. At this stage, our observations are limited to NF-B
activation in primary LN Tcells and transformed Tcells in-
volving only a limited number of stimuli. The consistency
with which NAC inhibited the effects of dithiocarbamates,
however, suggests that it may be worthwhile testing
whether these finding also apply to other systems. From a
clinical point of view, our findings also provide a com-
pelling argument for the judicious choice of drugs in the
design of NF-B-based therapies.
Materials and Methods
Cell Lines and T Cell Cultures
The T. parva-infected (Tpi) Tcell line TpM(803) is CD4+, CD8–, /
TCR+ and its characteristics and maintenance have been de-
scribed previously (Dobbelaere et al., 1988). LN Tcells were pre-
pared as described previously (Mastro and Pepin, 1980).
Drug Treatment, Processing and Analysis 
Chemical inhibitors or activators were added to the final concen-
trations as follows: cycloheximide (CHX; 177nM; Sigma), pyrroli-
dine dithiocarbamate (PDTC; 100 µM for short-term treatment in
EMSA and 10M for long-term treatment in transfection assays;
Sigma), N-acetylcysteine (NAC; 30mM or as indicated; Sigma),
tetradecanoyl phorbol acetate (TPA; 3.3 nM; Sigma); ionomycin
(2M; Sigma); okadaic acid (OA; 2 or 4M as indicated; LC la-
boratories); C2-ceramide (100M or as indicated; Calbiochem,
Lucerne, Switzerland); disulfiram (100M for EMSA, 1M for
transfection assays or as indicated for proliferation assays; Sig-
ma). Treatment of Tpi or LN Tcells with NAC and/or PDTC was for
5 h; CHX treatment of LN Tcells was for 5 h; for treatment of Tpi T
cells, CHX was added for the last 4 h of NAC/PDTC treatment. Tpi
Tcells were induced with OA (2M) for the last 90 min of NAC/
PDTC treatment; LN Tcells were induced with OA (4M) for the
last 40 min; disulfiram was added for the last 90 min. Ceramide
stimulation was carried out for the last hour of NAC/PDTC treat-
ment. 
Proliferation assays were carried out as follows: 1  105 cells/
ml were seeded in 96 flat-bottom well plates and cultured for 24 h
in the presence or absence of NAC, PDTC or disulfiram, as indi-
cated. Cells were pulsed with [methyl-3H]thymidine (0.2 Ci/well;
1 mCi = 37 MBq) for the last five hours and incorporation mea-
sured by liquid scintillation counting. Apoptosis was monitored
using the Annexin-V-Fluos kit from Boehringer.
Cell Lysates and Immunoblot Analysis 
Cells were collected and washed twice in ice-cold PBS, pH 7.4,
and then processed for immunoblot analysis as described before
(Palmer et al., 1997) . Rabbit anti-peptide polyclonal Ab with the
following specificities were used: IB (C-terminal 21 amino
acids; sc-371, Santa Cruz, Basel, Switzerland); IB (C-terminal
20 amino acids; sc-945); p105/p50 (C-terminal 20 amino acids;
sc-114); RelA/p65 (C-terminal 20 amino acids; sc-372); ATF-2
(sc-187), phospho-c-Jun (SER63) II antibody (9261s, New Eng-
land Biolabs, Allschwill, Switzerland) and phospho-specific p38
MAPK antibody (9211s, New England Biolabs). Bound primary
Ab detected using horseradish peroxidase-conjugated goat anti-
rabbit IgG and enhanced chemiluminescence (ECL, Amersham
Corp).
Electrophoretic Mobility Shift Assay (EMSA),
Cell Transfection and CAT Assays
EMSA was carried out using oligonucleotides (5-AGTTGA-
GGGGACTTTCCCAGGC-3 and its complement) in which the
consensus NF-B binding site (underlined) is incorporated
(Ivanov et al., 1989). Cells were treated with NAC or PDTC for 5 h.
OA (4M) stimulation was carried out for 40 min, in the case of
PDTC- or NAC-treated cells, during the last 40 min of treatment.
Plasmids used for transfection have been described before
(Ivanov et al., 1989). Plasmid –121/+232 HIV-CAT and control
–76/+232 HIV-CAT were derived by modification of pBLCAT5
containing the bacterial chloramphenicol acetyltransferase (CAT)
gene. In plasmid –121/+232 HIV-CAT (abbreviated HIV-CAT), the
CAT gene is under control of an HIV-1 enhancer with two B ele-
ments and the promoter region of the enhancer. Plasmid
–76/+232 HIV-CAT (	HIV-CAT) is identical except for deletion of
the region containing the B elements. Cells were transfected by
electroporation using standard protocols (2  107 cells/ml, 600 l
aliquots, 20 g of plasmid DNA, 430V, 250
). After electropora-
tion, cells were placed on ice for 5 min and then diluted in Lei-
bovitz L15 medium and incubated at 37°C for 24 h. Treated or un-
treated cells were incubated for an additional 24 h, collected and
washed with PBS, and then lysed by freeze-thawing in a CAT as-
say buffer (100mM Tris, pH 7.4, 1mM EDTA, 1mM DTT). After cen-
trifugation, the supernatant was collected, incubated for 6 min at
65°C, then re-centrifuged. A 15 l aliquot was assayed for CAT
activity using 9.25  103 Bq (250 nCi) of [14C]-chloramphenicol in
CAT assay buffer supplemented with 100 g bovine serum albu-
min and 2 mg/ml n-butyryl coenzyme A. Butyrylated chloram-
phenicol was extracted using xylene and radioactivity deter-
mined by liquid scintillation counting.
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